Pfizer Pulls Plug But iTeos Has High Hopes For IDO1 Inhibitor

Doors
Door closes, another opens: iTeos upbeat despite Pfizer pact ending • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer